Abstract
Multifunctional activity of the PDX1 gene product is reviewed. The PDX1 protein is unique in that being expressed exclusively in the pancreas it exhibits various functional activities in this organ both during embryonic development and during induction and progression of pancreatic cancer. Hence, PDX1 belongs to the family of master regulators with multiple and often antagonistic functions.
Similar content being viewed by others
Abbreviations
- EMT:
-
epithelial–mesenchymal transition
- PDAC:
-
pancreatic ductal adenocarcinoma
- PDX1:
-
pancreatic and duodenal homeobox 1
References
Shih, H. P., Seymour, P. A., Patel, N. A., Xie, R., Wang, A., Liu, P. P., Yeo, G. W., Magnuson, M. A., and Sander, M. (2015) A gene regulatory network cooperatively controlled by Pdx1 and Sox9 governs lineage allocation of foregut progenitor cells, Cell Rep., 13, 326–336.
Shih, H. P., Wang, A., and Sander, M. (2013) Pancreas organogenesis: from lineage determination to morphogenesis, Annu. Rev. Cell. Dev. Biol., 29, 81–105.
Teo, A. K., Tsuneyoshi, N., Hoon, S., Tan, E. K., Stanton, L. W., Wright, C. V., and Dunn, N. R. (2015) PDX1 binds and represses hepatic genes to ensure robust pancreatic commitment in differentiating human embryonic stem cells, Stem Cell Rep., 4, 578–590.
Kondratyeva, L. G., Vinogradova, T. V., Chernov, I. P., and Sverdlov, E. D. (2015) Master transcription regulators specifying cell-lineage fate in development as possible therapeutic targets in oncology, Russ. J. Genet., 51, 1049–1059.
Roy, N., and Hebrok, M. (2015) Regulation of cellular identity in cancer, Dev. Cell, 35, 674–684.
Wang, A., Yue, F., Li, Y., Xie, R., Harper, T., Patel, N. A., Muth, K., Palmer, J., Qiu, Y., Wang, J., Lam, D. K., Raum, J. C., Stoffers, D. A., Ren, B., and Sander, M. (2015) Epigenetic priming of enhancers predicts developmental competence of hESC-derived endodermal lineage intermediates, Cell. Stem. Cell, 16, 386–399.
Stanger, B. Z., and Hebrok, M. (2013) Control of cell identity in pancreas development and regeneration, Gastroenterology, 144, 1170–1179.
Puri, S., Folias, A. E., and Hebrok, M. (2015) Plasticity and dedifferentiation within the pancreas: development, homeostasis, and disease, Cell Stem Cell, 16, 18–31.
Thompson, N., Gesina, E., Scheinert, P., Bucher, P., and Grapin-Botton, A. (2012) RNA profiling and chromatin immunoprecipitation-sequencing reveal that PTF1a stabilizes pancreas progenitor identity via the control of MNX1/HLXB9 and a network of other transcription factors, Mol. Cell. Biol., 32, 1189–1199.
Hoang, C. Q., Hale, M. A., Azevedo-Pouly, A. C., Elsasser, H. P., Deering, T. G., Willet, S. G., Pan, F. C., Magnuson, M. A., Wright, C. V., Swift, G. H., and MacDonald, R. J. (2016) Transcriptional maintenance of pancreatic acinar identity, differentiation, and homeostasis by PTF1A, Mol. Cell. Biol., 36, 3033–3047.
Dassaye, R., Naidoo, S., and Cerf, M. E. (2016) Transcription factor regulation of pancreatic organogenesis, differentiation and maturation, Islets, 8, 13–34.
Larsen, H. L., and Grapin-Botton, A. (2017) The molecular and morphogenetic basis of pancreas organogenesis, Semin. Cell Dev. Biol., pii: S1084-9521(17)30007-1.
Cano, D. A., Soria, B., Martin, F., and Rojas, A. (2014) Transcriptional control of mammalian pancreas organogenesis, Cell. Mol. Life Sci., 71, 2383–2402.
Spaeth, J. M., Walker, E. M., and Stein, R. (2016) Impact of Pdx1-associated chromatin modifiers on islet beta-cells, Diabetes Obes. Metab., 18, 123–127.
Ischenko, I., Petrenko, O., and Hayman, M. J. (2014) Analysis of the tumor-initiating and metastatic capacity of PDX1-positive cells from the adult pancreas, Proc. Natl. Acad. Sci. USA, 111, 3466–3471.
Willmann, S. J., Mueller, N. S., Engert, S., Sterr, M., Burtscher, I., Raducanu, A., Irmler, M., Beckers, J., Sass, S., Theis, F. J., and Lickert, H. (2016) The global gene expression profile of the secondary transition during pancreatic development, Mech. Dev., 139, 51–64.
Kuzmich, A. I., Tyulkina, D. V., Vinogradova, T. V., and Sverdlov, E. D. (2015) Pioneer transcription factors in normal development and cancerogenesis, Russ. J. Bioorg. Chem., 41, 570–577.
Zinovyeva, M. V., Kuzmich, A. I., Monastyrskaya, G. S., and Sverdlov, E. D. (2016) The role of FOXA subfamily factors in embryonic development and cancerogenesis of the pancreas, Mol. Genet. Microbiol. Virol., 31, 135–142.
Yin, C. (2016) Molecular mechanisms of Sox transcription factors during the development of liver, bile duct, and pancreas, Semin. Cell Dev. Biol., doi: 10.1016/j.semcdb.2016.08.015.
Hidalgo, M. (2010) Pancreatic cancer, N. Engl. J. Med., 362, 1605–1617.
Fokas, E., O’Neill, E., Gordon-Weeks, A., Mukherjee, S., McKenna, W. G., and Muschel, R. J. (2015) Pancreatic ductal adenocarcinoma: from genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic, Biochim. Biophys. Acta, 1855, 61–82.
Ying, H., Dey, P., Yao, W., Kimmelman, A. C., Draetta, G. F., Maitra, A., and DePinho, R. A. (2016) Genetics and biology of pancreatic ductal adenocarcinoma, Genes Dev., 30, 355–385.
Gu, D., Schlotman, K. E., and Xie, J. (2016) Deciphering the role of hedgehog signaling in pancreatic cancer, J. Biomed. Res., 30, 353–360.
Bardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K. H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., Hanahan, D., Redston, M. S., Chin, L., and Depinho, R. A. (2006) Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse, Proc. Natl. Acad. Sci. USA, 103, 5947–5952.
Gidekel Friedlander, S. Y., Chu, G. C., Snyder, E. L., Girnius, N., Dibelius, G., Crowley, D., Vasile, E., DePinho, R. A., and Jacks, T. (2009) Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras, Cancer Cell, 16, 379–389.
Tanaka, S. (2015) Molecular pathogenesis and targeted therapy of pancreatic cancer, Ann. Surg. Oncol., 23, 197–205.
Norris, A. L., Roberts, N. J., Jones, S., Wheelan, S. J., Papadopoulos, N., Vogelstein, B., Kinzler, K. W., Hruban, R. H., Klein, A. P., and Eshleman, J. R. (2015) Familial and sporadic pancreatic cancer share the same molecular pathogenesis, Fam. Cancer, 14, 95–103.
Brosens, L. A., Hackeng, W. M., Offerhaus, G. J., Hruban, R. H., and Wood, L. D. (2015) Pancreatic adenocarcinoma pathology: changing “landscape”, J. Gastrointest. Oncol., 6, 358–374.
Shah, M., and Allegrucci, C. (2013) Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells, Subcell. Biochem., 61, 545–565.
Zinovyeva, M. V., Kostina, M. B., Monastyrskaya, G. S., Sass, A. V., Filyukova, O. B., Vinogradova, T. V., Kopantsev, E. P., and Sverdlov, E. D. (2015) Genetic markers for lung and esophagus common precursor cells in human development, Dokl. Biochem. Biophys., 463, 203–208.
Roy, N., Takeuchi, K. K., Ruggeri, J. M., Bailey, P., Chang, D., Li, J., Leonhardt, L., Puri, S., Hoffman, M. T., Gao, S., Halbrook, C. J., Song, Y., Ljungman, M., Malik, S., Wright, C. V., Dawson, D. W., Biankin, A. V., Hebrok, M., and Crawford, H. C. (2016) PDX1 dynamically regulates pancreatic ductal adenocarcinoma initiation and maintenance, Genes Dev., 30, 2669–2683.
Blanpain, C. (2013) Tracing the cellular origin of cancer, Nat. Cell. Biol., 15, 126–134.
Kopp, J. L., von Figura, G., Mayes, E., Liu, F. F., Dubois, C. L., Morris, J. P., Pan, F. C., Akiyama, H., Wright, C. V., Jensen, K., Hebrok, M., and Sander, M. (2012) Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma, Cancer Cell, 22, 737–750.
Wei, D., Wang, L., Yan, Y., Jia, Z., Gagea, M., Li, Z., Zuo, X., Kong, X., Huang, S., and Xie, K. (2016) KLF4 is essential for induction of cellular identity change and acinar-toductal reprogramming during early pancreatic carcinogenesis, Cancer Cell, 29, 324–338.
Diaferia, G. R., Balestrieri, C., Prosperini, E., Nicoli, P., Spaggiari, P., Zerbi, A., and Natoli, G. (2016) Dissection of transcriptional and cis-regulatory control of differentiation in human pancreatic cancer, EMBO J., 35, 595–617.
Park, J., Hong, S., Klimstra, D., Goggins, M., Maitra, A., and Hruban, R. (2011) Pdx1 expression in pancreatic precursor lesions and neoplasms, Appl. Immunohistochem. Mol. Morphol., 19, 444–449.
Miyazaki, S., Tashiro, F., and Miyazaki, J. (2016) Transgenic expression of a single transcription factor Pdx1 induces transdifferentiation of pancreatic acinar cells to endocrine cells in adult mice, PLoS One, 11, e0161190.
Stepanenko, A. A., Vassetzky, Y. S., and Kavsan, V. M. (2013) Antagonistic functional duality of cancer genes, Gene, 529, 199–207.
Gao, X., Wang, X., Cai, K., Wang, W., Ju, Q., Yang, X., Wang, H., and Wu, H. (2016) MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3, Eur. J. Pharmacol., 791, 603–610.
Wurm, A. A., Tenen, D. G., and Behre, G. (2017) The Janus-faced nature of miR-22 in hematopoiesis: is it an oncogenic tumor suppressor or rather a tumor-suppressive oncogene? PLoS Genet., 13, e1006505.
David, C. J., Huang, Y. H., Chen, M., Su, J., Zou, Y., Bardeesy, N., Iacobuzio-Donahue, C. A., and Massague, J. (2016) TGF-beta tumor suppression through a lethal EMT, Cell, 164, 1015–1030.
He, S., and Liang, C. (2015) Frameshift mutation of UVRAG: switching a tumor suppressor to an oncogene in colorectal cancer, Autophagy, 11, 1939–1940.
Pickard, A., and McCance, D. J. (2015) IGF-binding protein 2–oncogene or tumor suppressor? Front. Endocrinol. (Lausanne), 6, 25.
Toker, A., and Chin, Y. R. (2014) Akt-ing up on SRPK1: oncogene or tumor suppressor? Mol. Cell, 54, 329–330.
Lobry, C., Oh, P., Mansour, M. R., Look, A. T., and Aifantis, I. (2014) Notch signaling: switching an oncogene to a tumor suppressor, Blood, 123, 2451–2459.
Silipo, M., Gautrey, H., Satam, S., Lennard, T., and Tyson-Capper, A. (2016) How is Herstatin, a tumor suppressor splice variant of the oncogene HER2, regulated? RNA Biol., 9, 1–8.
Beaurivage, C., Champagne, A., Tobelaim, W. S., Pomerleau, V., Menendez, A., and Saucier, C. (2016) SOCS1 in cancer: an oncogene and a tumor suppressor, Cytokine, 82, 87–94.
Liang, J., and Mills, G. B. (2013) AMPK: a contextual oncogene or tumor suppressor? Cancer Res., 73, 2929–2935.
Zinovyeva, M. V., Kostina, M. B., Chernov, I. P., Kodratyeva, L. G., and Sverdlov, E. D. (2016) KLF5, a new player and new target in the permanently changing set of pancreatic cancer molecular drivers, Russ. J. Bioorg. Chem., 42, 606–611.
Ji, Z., and Sharrocks, A. D. (2015) Changing partners: transcription factors form different complexes on and off chromatin, Mol. Syst. Biol., 11, 782.
Cusanovich, D. A., Pavlovic, B., Pritchard, J. K., and Gilad, Y. (2014) The functional consequences of variation in transcription factor binding, PLoS Genet., 10, e1004226.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © T. V. Vinogradova, E. D. Sverdlov, 2017, published in Biokhimiya, 2017, Vol. 82, No. 8, pp. 1154-1162.
Rights and permissions
About this article
Cite this article
Vinogradova, T.V., Sverdlov, E.D. PDX1: A unique pancreatic master regulator constantly changes its functions during embryonic development and progression of pancreatic cancer. Biochemistry Moscow 82, 887–893 (2017). https://doi.org/10.1134/S000629791708003X
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S000629791708003X